Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis
Thomas Reiser, Former Executive Director at the International Society on Thrombosis and Haemostasis, reposted from ISTH on LinkedIn:
”A great opportunity to lead and further evolve a truly impactful international medical-scientific organization and work closely with an amazingly committed board and immensely talented staff team to advance the field of thrombosis and hemostasis and benefit the bleeding and clotting community around the world.”
Quoting International Society on Thrombosis and Haemostasis (ISTH)‘s post:
”We have officially launched our search for our next Executive Director.
If you are interested, please find more details at the link below.
Or if you know someone who might be interested, please pass the news along.”
Stay updated with Hemostasis Today.
-
Apr 1, 2026, 18:46Fritz Torto: Why Every Survivor Has a Duty to Build a Stronger Future for Others
-
Apr 1, 2026, 17:47Akshaya Sharon: Qfitlia as a Shift in Treatment Strategy for Hemophilia A and B
-
Apr 1, 2026, 17:21Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
-
Apr 1, 2026, 17:19Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect
-
Apr 1, 2026, 17:18John Abraham: Breaking the ‘Bleeding Disorder’ Myth About Cirrhosis and Coagulation
-
Apr 1, 2026, 17:17Heghine Khachatryan: Linking Coagulation, Inflammation, and Neurodegeneration In Neuro-Hemostasis Axis
-
Apr 1, 2026, 17:15Chokri Ben Lamine: Differentiating Reactive from Clonal Causes in Adult Neutrophilia
-
Apr 1, 2026, 16:05Gregory Piazza: Discussing the 2026 AHA/ACC Guidelines for Acute PE at ACC.26
-
Apr 1, 2026, 15:31Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation